{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT00413556",
      "orgStudyIdInfo": {
        "id": "GT-16"
      },
      "organization": {
        "fullName": "ALK-Abelló A/S",
        "class": "INDUSTRY"
      },
      "briefTitle": "Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets",
      "officialTitle": "Randomised, Double-Blind, Placebo-Controlled Phase IIIb Study Investigating Changes in Immunological Parameters and Cutaneous Reactivity Induced by a Short Course Immunotherapy With ALK Grass Tablets"
    },
    "statusModule": {
      "statusVerifiedDate": "2008-03",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2007-01"
      },
      "primaryCompletionDateStruct": {
        "date": "2007-08",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2007-12",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2006-12-18",
      "studyFirstSubmitQcDate": "2006-12-18",
      "studyFirstPostDateStruct": {
        "date": "2006-12-19",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2008-03-04",
      "lastUpdatePostDateStruct": {
        "date": "2008-03-06",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "oldNameTitle": "Pilar Rico Nieto - Medical Department",
        "oldOrganization": "ALK-Abelló S.a."
      },
      "leadSponsor": {
        "name": "ALK-Abelló A/S",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false
    },
    "descriptionModule": {
      "briefSummary": "We plan to determine changes in the immune system during the allergic response to grass pollen allergens. We have chosen a particular element of the immune response, the immunoglobulin G4 (IgG4) as an indicator.\n\nWe hypothesize that treatment with Grazax will increase serum levels of Phleum pratense specific IgG4 and IgE, as well as reduce the cutaneous sensitivity of the early (IgE mediated) and late (cell mediated) allergic response."
    },
    "conditionsModule": {
      "conditions": [
        "Allergy"
      ],
      "keywords": [
        "Rhinitis",
        "Oral tablets",
        "Ig G4",
        "grass pollen",
        "inmunotherapy"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "TRIPLE",
          "whoMasked": [
            "PARTICIPANT",
            "CARE_PROVIDER",
            "INVESTIGATOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 76,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "1",
          "type": "ACTIVE_COMPARATOR",
          "interventionNames": [
            "Biological: ALK Grass tablet"
          ]
        },
        {
          "label": "2",
          "type": "PLACEBO_COMPARATOR",
          "interventionNames": [
            "Biological: ALK Grass tablet"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "ALK Grass tablet",
          "armGroupLabels": [
            "1",
            "2"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Difference in serum leves of IgG4",
          "timeFrame": "6 months"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Changes in IgE level",
          "timeFrame": "6 months"
        },
        {
          "measure": "Changes in cutaneous response",
          "timeFrame": "6 months"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* A history of grass pollen allergy\n* Positive skin prick test to grass\n* Positive specific IgE to grass\n\nExclusion Criteria:\n\n* Treatment with anti-IgE",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "65 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Pilar Rico, MD",
          "affiliation": "Medical Director, ALK-Abello, S.A.",
          "role": "STUDY_CHAIR"
        }
      ],
      "locations": [
        {
          "facility": "Hospital Clinico San Carlos",
          "city": "Madrid",
          "state": "Madrid",
          "zip": "28040",
          "country": "Spain",
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D012220",
          "term": "Rhinitis"
        }
      ],
      "ancestors": [
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        },
        {
          "id": "D012141",
          "term": "Respiratory Tract Infections"
        },
        {
          "id": "D007239",
          "term": "Infections"
        },
        {
          "id": "D009668",
          "term": "Nose Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D010038",
          "term": "Otorhinolaryngologic Diseases"
        }
      ]
    }
  },
  "hasResults": false
}